Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
CRISPR biotech Caribou Biosciences' IPO reels in $304M for next-gen cell therapy
The first generation of cell therapies demonstrated how a patient's own immune cells can be engineered into tumor-hunting cancer killers. Caribou Biosciences is among the biotech companies developing next-generation cell therapies that could offer…
/cdn.vox-cdn.com/uploads/chorus_asset/file/22735292/intrinsic_green_purple_center.png)
Google launches Intrinsic: a new company to build software for industrial robots
Google's parent-company Alphabet has a birth to announce: a new company called Intrinsic which will focus on building software for industrial robots. The subsidiary will be one of Alphabet's “other bets” — relatively…
How Sean McClain founded Absci at just 22 - and now leads a freshly public biotech worth nearly $2B
Biotech CEOs tend to have advanced degrees and multiple academic credentials under their belt. But Sean McClain started Absci as a freshly minted grad from the University of Arizona at age 22, living with his parents and working out of a basement…
Bharat Biotech terminates Covaxin deal with Brazil's Precisa
Bharat Biotech has terminated a memorandum of understanding to sell its Covid-19 vaccine Covaxin to Brazil's Precisa Medicamentos, the Indian company said on Friday without disclosing the reason. Bharat's statement said it will continue to work…
Timaru biotech company says it can make vaccines for NZ and Pacific
A Timaru biotech company has the capability to manufacture enough Covid-19 vaccines to supply New Zealand, and the Pacific, its co-founder and co-director says. Dr William Rolleston, of South Pacific Sera, told Stuff on Thursday that while there…
Shares of protein discovery platform Absci pop in market debut
Image Credits: CHRISTOPH BURGSTEDT/SCIENCE PHOTO LIBRARY / Getty Images Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It's another sign of snowballing interest in new approaches to drug…
Bharat Biotech terminates MoU with Brazilian partners after graft allegations
Bharat Biotech on Friday said it terminated the Memorandum of Understanding entered with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market. The termination of the MoU came after the deal…
How many vaccines is India making? The government has many answers to one question
The Narendra Modi government seems unsure of how many Covid-19 vaccines are being produced in the country. In a single day in parliament, the government had three estimates for domestic vaccine production. On July 20, the health ministry first…
NHS shares English hospital data with dozens of companies
More than 40 companies, ranging from the world's largest management consultancies and pharmaceutical groups to a data company co-founded by a member of the Sackler family, have received years of detailed medical records from English hospitals, a…
Bharat Biotech commits to supply 500 Mn doses of Covaxin to Centre for immunisation programme
Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme. Speaking at a virtual conference organised by the Confederation of Indian…
SOSV partners explain how deep tech startups can fundraise successfully
Startups developing so-called deep tech often find it challenging to raise capital for various reasons. At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging…
Exclusive: Alphabet taps Wendy Tan White as CEO of new robotics company Intrinsic
Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning. Most projects in Alphabet's secretive X research and development division—formerly known as Google X—never make it out of the lab. But…
Top VCs in psychedelics say Big Pharma is knocking at the door - and it could fuel a wave of deals
Insider talked to 11 top VCs in the psychedelics space and asked for their predictions. Three of them said that pharmaceutical companies are eyeing the space and looking for a way in. Several pharma firms have already entered the industry. Big…
Competition laws could be a death knell for startup mergers and acquisitions
Technology entrepreneurs and innovations yet to be imagined are in the crosshairs of misguided antitrust legislation. Antitrust policy is under the microscope from both political parties. The Biden administration's Executive Order on Promoting…
Elephants are clever problem solvers - and they have distinct personalities, too
This article or excerpt is included in the GLP's daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation. Just as humans have their own individual personalities, new research in the Journal of…
Receive a Daily briefing on Biotech Industry News
Learn from targeted reports
Our focused News Briefs help you stay up-to-date with any and all of your industry interests